Social Impact as Strategy
Greg Hills is a managing director in the Boston office of FSG, a global social impact consulting firm specializing in strategy, evaluation, and research. In his eight years at FSG, he has advised over a dozen leading corporations on international corporate social responsibility (CSR) strategies and he leads FSG’s Global Development practice area working with leading foundations, nonprofits, and businesses to identify sustainable solutions to global poverty. Greg writes and speaks regularly on topics of CSR and philanthropic effectiveness and his work spans issues such as education, health care, environment, agriculture, and economic development. His background includes corporate strategy consulting and working for USAID managing public-private partnerships in the Asia-Pacific region. Greg holds an M.B.A. from the Tuck School of Business at Dartmouth College and a B.A., cum laude, with honors in Government from Hamilton College.
Investing as Impact
Elizabeth Glenshaw is Clean Yield Asset Management's portfolio manager and managing director. She started her career crafting a community-banking program for a Vermont bank that focused on ensuring access to credit for low-wealth communities. Subsequently, she worked for two SRI asset-management companies, managing portfolios for clients who wished to integrate their social values with their financial objectives. Elizabeth's last position was with the Calvert Foundation, which assists non-profits in low-wealth and impoverished communities. She was instrumental in growing the organization from six to 38 employees, with a loan portfolio of $200 million. In 1993, Elizabeth was first elected to the board of the Social Investment Forum, the industry's trade association. She served for 14 years, several as VP. Currently, she is president of the board of the Vermont Community Loan Fund, serves as an advisor to Vermont's largest bank, the Chittenden Bank, and is VP of the board of the Upper Valley Rowing Foundation. She also has an advisory seat with the Upper Valley Region of New Hampshire Charitable Trust. Elizabeth received a BA from Marlboro College and is a graduate of the National Graduate Trust School at Northwestern University. She also has a degree in financial planning from Boston University. Elizabeth loves most sports and competes nationally in rowing.
Shuaib Siddiqui is a portfolio manager for Acumen Fund. He joined Acumen Fund Pakistan as a Portfolio Associate in September of 2007. He focuses primary on the housing and renewable energy sectors. Prior to Acumen Fund, Shuaib worked for two years in the Quantitative Alpha Generation Group at Citadel Investment Group, a hedge fund based in Chicago, where he focused on developing trading strategies utilizing fundamental company data. Prior to that, he was an Assistant Vice President at Merrill Lynch working on The Global Analytic and Thematic Research team. He holds a BA in Economics from New York University.
John Vogel (Moderator) is an associate faculty director for the Allwin Initiative for Corporate Citizenship and an adjunct professor at Tuck. He has taught courses in entrepreneurship in the social sector, nonprofit management, and real estate at Tuck since 1992. The “Business Week Guide” to Business Schools named him one of Tuck’s “Outstanding Faculty” members. In addition to academia, he has extensive experience working in the nonprofit and private sector including six years as the Executive Director of the Neighborhood Development Corporation of Jamaica Plain. His areas of research include: affordable housing, B Corporations, sustainable buildings and the real estate capital markets. His recent publications include “Laws, Not Lawyers: How States Can Protect Nonprofit Leaders and Infuse More Money into the Sector”, published in the Stanford Social Innovation Review. He has written more than 100 case studies which are used around the world. He serves on the boards of directors of the HOPE Foundation and Housing Vermont, and on the advisory board for Dartmouth's Tucker Foundation. He earned his BA from Carleton College, an MA in English from the University of Virginia and his MBA from Harvard.
Shuaib Siddiqui is a portfolio manager for Acumen Fund. He joined Acumen Fund Pakistan as a Portfolio Associate in September of 2007. He focuses primary on the housing and renewable energy sectors. Prior to Acumen Fund, Shuaib worked for two years in the Quantitative Alpha Generation Group at Citadel Investment Group, a hedge fund based in Chicago, where he focused on developing trading strategies utilizing fundamental company data. Prior to that, he was an Assistant Vice President at Merrill Lynch working on The Global Analytic and Thematic Research team. He holds a BA in Economics from New York University.
John Vogel (Moderator) is an associate faculty director for the Allwin Initiative for Corporate Citizenship and an adjunct professor at Tuck. He has taught courses in entrepreneurship in the social sector, nonprofit management, and real estate at Tuck since 1992. The “Business Week Guide” to Business Schools named him one of Tuck’s “Outstanding Faculty” members. In addition to academia, he has extensive experience working in the nonprofit and private sector including six years as the Executive Director of the Neighborhood Development Corporation of Jamaica Plain. His areas of research include: affordable housing, B Corporations, sustainable buildings and the real estate capital markets. His recent publications include “Laws, Not Lawyers: How States Can Protect Nonprofit Leaders and Infuse More Money into the Sector”, published in the Stanford Social Innovation Review. He has written more than 100 case studies which are used around the world. He serves on the boards of directors of the HOPE Foundation and Housing Vermont, and on the advisory board for Dartmouth's Tucker Foundation. He earned his BA from Carleton College, an MA in English from the University of Virginia and his MBA from Harvard.
Driving Change in the Energy Sector
Seth Dunn is renewables policy leader at GE Energy. In this role he is responsible for market development and policy in the Americas and leads a global team with coverage of Europe, China, India, and the Asia-Pacific. Seth joined GE in 2005 with the Renewable Energy Leadership Program, through which he completed rotations in sales, marketing, and product development. Prior to joining GE, Seth served as a researcher with the Worldwatch Institute in Washington, DC, where he published and spoke extensively on energy and environmental issues. He holds BA, MBA, and MEM degrees from Yale University and is proud to note that his twin sister, Heather, is a graduate of Dartmouth College.
Daniel Hullah is a partner with RockPort Capital. He was born and educated in the UK where he received a BA and a PhD in Chemistry from the University of Oxford. He came to the United States in 1999 as a postdoctoral research associate at the University of Chicago. Following his stint in Chicago, Daniel left academia but stayed in the States as he branched out into a career in management consulting at ZS Associates – a firm that focuses exclusively on sales and marketing. Daniel moved to Boston in 2001 to start a new ZS office, and went on to pursue an MBA at INSEAD in Fontainebleau, France. Shortly after returning to the States from INSEAD, Daniel joined RockPort in Boston. Since then he has been an active member of the screening and diligence team and has worked on multiple transactions in several key cleantech sectors most notably solar energy and green buildings. He has represented RockPort on investor panels at conferences throughout the country.
Sienna Rogers is a manager with Pacific Gas & Electric Company where she currently leads the financial forecasting and analysis team. Since joining PG&E through its leadership development program, Sienna has worked on a variety of strategic issues including the company’s renewable energy portfolio, implementation of climate change legislation and mitigating risks of the physical impacts of climate change. Prior to joining PG&E in 2006, she worked in JPMorgan's Financial Sponsor investment banking group in New York and San Francisco. Sienna received an MBA from the Tuck School of Business at Dartmouth College and a BA from Duke University.
Armond Cohen (Moderator) is co-founder and executive director of the Clean Air Task Force (CATF), a non-profit organization dedicated to reducing atmospheric pollution through research, advocacy and private sector collaboration. CATF partners with a variety of companies to develop and implement global strategies for the commercialization of low carbon energy technology -- focusing on fossil energy with carbon capture and storage, advanced renewables, and advanced nuclear power. Among other efforts, CATF’s China office has facilitated more than a dozen US-China joint ventures in the low carbon space. Armond has been working on the connection between energy, air pollution and climate change for more than two decades. Prior to co-founding CATF, Armond developed and directed the Conservation Law Foundation Energy Project in New England, specializing in energy efficiency, renewable energy and electric industry structure. He is an honors graduate of the Harvard Law School and Brown University, and served as a judicial clerk for the federal appeals court in Chicago. Armond is a member of the Keystone Energy Board and the US EPA Clean Air Act Advisory Committee. He writes and speaks widely on energy, climate and related environmental matters, and testifies frequently before Congress and other governmental bodies.
Daniel Hullah is a partner with RockPort Capital. He was born and educated in the UK where he received a BA and a PhD in Chemistry from the University of Oxford. He came to the United States in 1999 as a postdoctoral research associate at the University of Chicago. Following his stint in Chicago, Daniel left academia but stayed in the States as he branched out into a career in management consulting at ZS Associates – a firm that focuses exclusively on sales and marketing. Daniel moved to Boston in 2001 to start a new ZS office, and went on to pursue an MBA at INSEAD in Fontainebleau, France. Shortly after returning to the States from INSEAD, Daniel joined RockPort in Boston. Since then he has been an active member of the screening and diligence team and has worked on multiple transactions in several key cleantech sectors most notably solar energy and green buildings. He has represented RockPort on investor panels at conferences throughout the country.
Sienna Rogers is a manager with Pacific Gas & Electric Company where she currently leads the financial forecasting and analysis team. Since joining PG&E through its leadership development program, Sienna has worked on a variety of strategic issues including the company’s renewable energy portfolio, implementation of climate change legislation and mitigating risks of the physical impacts of climate change. Prior to joining PG&E in 2006, she worked in JPMorgan's Financial Sponsor investment banking group in New York and San Francisco. Sienna received an MBA from the Tuck School of Business at Dartmouth College and a BA from Duke University.
Armond Cohen (Moderator) is co-founder and executive director of the Clean Air Task Force (CATF), a non-profit organization dedicated to reducing atmospheric pollution through research, advocacy and private sector collaboration. CATF partners with a variety of companies to develop and implement global strategies for the commercialization of low carbon energy technology -- focusing on fossil energy with carbon capture and storage, advanced renewables, and advanced nuclear power. Among other efforts, CATF’s China office has facilitated more than a dozen US-China joint ventures in the low carbon space. Armond has been working on the connection between energy, air pollution and climate change for more than two decades. Prior to co-founding CATF, Armond developed and directed the Conservation Law Foundation Energy Project in New England, specializing in energy efficiency, renewable energy and electric industry structure. He is an honors graduate of the Harvard Law School and Brown University, and served as a judicial clerk for the federal appeals court in Chicago. Armond is a member of the Keystone Energy Board and the US EPA Clean Air Act Advisory Committee. He writes and speaks widely on energy, climate and related environmental matters, and testifies frequently before Congress and other governmental bodies.
Design Thinking Workshop
Alva Taylor is an associate professor of business at the Tuck School of Business at Dartmouth, where he has taught since 2000. He received his BS, ME, and MBA from Cornell and a PhD from Stanford University. Prior to his academic career, Professor Taylor was an industrial engineer at Eastman Kodak Company and a senior manager in the Management Consulting Department at KPMG. His current research interests include corporate entrepreneurship, technological change, organizational evolution and change, and intra-organizational decision making. He has been published in scholarly journals such as Administrative Science Quarterly, Academy of Management Journal, Organization Science, and in the book Strategic Management of Technology and Innovation (Irwin, 1993).
Andrew Waldeck (T ’04) is a partner at Innosight, an innovation and strategy consulting firm. Mr. Waldeck works with health care, finance and media companies to develop innovation strategies that counter disruptive forces that threaten to reshape these industries. He has helped these companies create innovative responses to protect and extend existing businesses while also developing new business models designed to capture additional growth opportunities. He has also played a leadership role in helping many of these companies establish and implement the processes and structure to make innovation a repeatable organizational discipline. In addition to his consulting work, Mr. Waldeck is also a frequent speaker on the topics of innovation and growth. His articles on innovation and strategy include “The New M&A Playbook,” appearing in the March 2011 issue of Harvard Business Review, coauthored with Innosight founder Clayton Christensen. Andy received a B.A. in Business Economics from Brown University and a M.B.A with Distinction from the Tuck School of Business at Dartmouth, where he was a Tuck Scholar.
Andrew Waldeck (T ’04) is a partner at Innosight, an innovation and strategy consulting firm. Mr. Waldeck works with health care, finance and media companies to develop innovation strategies that counter disruptive forces that threaten to reshape these industries. He has helped these companies create innovative responses to protect and extend existing businesses while also developing new business models designed to capture additional growth opportunities. He has also played a leadership role in helping many of these companies establish and implement the processes and structure to make innovation a repeatable organizational discipline. In addition to his consulting work, Mr. Waldeck is also a frequent speaker on the topics of innovation and growth. His articles on innovation and strategy include “The New M&A Playbook,” appearing in the March 2011 issue of Harvard Business Review, coauthored with Innosight founder Clayton Christensen. Andy received a B.A. in Business Economics from Brown University and a M.B.A with Distinction from the Tuck School of Business at Dartmouth, where he was a Tuck Scholar.
Trading Profits for Healthcare Equality
Dr. Jaime Bayona is the director of Global Health Programs and Practice for the Dartmouth Center for Health Care Delivery Science. He joined Dartmouth from Peru, where he was the co-founder and director of Socios En Salud Sucursal Peru (SES), the Peruvian branch of Partners in Health (PIH). At SES, he served as the principal investigator for numerous NIH grants, oversaw a staff of 120, managed relationships with government, and facilitated the participation of students and research affiliates on various projects at the SES site and throughout Peru. Dr. Bayona is considered one of the top experts in MDR-TB programs and has consulted in over a dozen countries. He is member of the Regional Green Light Committee for the Americas - PAHO/WHO. He has held appointments at the Department of Global Health and Social Medicine at Harvard University as a lecturer, and at the Division of Global Health Equity at Brigham and Women’s Hospital as a research associate. He is an assistant professor at the Department of Community and Family Medicine at Dartmouth Medical School.
Dr. Paul Chew is senior vice president, chief science officer, and chief medical officer at Sanofi, U.S. Between 2007 and 2009 Dr. Chew held the position of president, U.S. research & development, and vice president, therapeutic department head, metabolism, diabetes and thrombosis in which role he was responsible for Lovenox, Lantus, and the therapeutic development portfolio. In addition, he is a member of the PhRMA Science & Regulatory Affairs Executive Committee and the Institute of Medicine Value & Science-Driven Healthcare Roundtable. From 2001-2004, U.S. Dr. Chew was vice president, global head of metabolism and diabetes at Aventis Pharmaceuticals. Prior to joining Aventis, Dr. Chew was at the Bristol-Myers Squibb Company, starting in 1992 as medical director of clinical cardiovascular development. Dr. Chew was vice president, U.S. medical affairs from 1999-2001 where he was responsible for Plavix, Avapro, Glucophage, and Pravachol. Prior to industry, Dr. Chew was assistant professor at The Johns Hopkins Hospital, attending physician in radiology, director of the Pacemaker Clinic and a member of the interventional cardiology staff. Dr. Chew obtained his medical education at The Johns Hopkins School of Medicine.
Dr. Vas Narasimhan recently became global head, vaccines development for Novartis Vaccines and Diagnostics. He is responsible for the clinical development of the vaccine pipeline with over 25 projects and nearly 100 annual global clinical trials. Previously, Vas was head, Novartis Vaccines North America and US country head for Novartis Vaccines and Diagnostics, during which he drove strong growth in the region, built a fully integrated organization that successfully launched Menveo (MenACWY), created new seasonal flu distribution channels, and executed pandemic influenza programs. Vas has served in roles of increasing responsibility at Novartis including as Vice President of US Marketing, Meningitis Franchise Head, Global Marketing, Menveo Brand Director and Head of Portfolio Strategy for the Office of the CEO at Novartis Pharma AG. He worked in the Pharmaceuticals and Medical Products Practice at McKinsey & Co., consulting major pharmaceutical and healthcare companies on a range of initiatives, including large-scale M&A activity and top-level corporate strategy. Vas earned his medical degree from Harvard Medical School and obtained his MPP in International Health Care Policy from Harvard’s John F. Kennedy School of Government. He received his bachelor’s degree in Biological Sciences from University of Chicago.
Derek Yach has played a leading global role in many aspects of NCDs within the private, public and Foundation world for the last 2 decades. He is senior vice president of Global Health and Agricultural Policy at PepsiCo and leads new initiatives related to sustainable agriculture and nutrition in Africa. He has headed global health at the Rockefeller Foundation, been Professor of Global Health at Yale University, and is a former Executive Director of the World Health Organization (WHO). At the WHO he served as cabinet director under Director-General Gro Harlem Brundtland for Non Communicable Diseases and Mental Health where he led development of WHO’s Framework Convention on Tobacco Control, the Global Strategy on Diet and Physical Activity and WHO’s World Health Report on Mental Health. Dr. Yach established the Centre for Epidemiological Research at the South African Medical Research Council. He has authored or co-authored over 200 articles covering the breadth of global health. These include leading thought pieces within NCDs over the last 20 years. He serves on advisory boards of the Clinton Global Initiative, the Chicago Council on International Affairs’ Agricultural Development Initiative, the World Economic Forum’s New Vision for Agriculture, the NIH’s Fogarty International Centre and the World Food Program USA. He is regular plenary speaker and moderator of global and national meetings related to health and development. Dr. Yach has degrees in medicine (Cape Town), public health (Johns Hopkins) and an honorary DSc from Georgetown University.
President Jim Yong Kim (Moderator) took office as the 17th president of Dartmouth College in July 2009. He is a co-founder of Partners in Health (PIH) and a former director of the Department of HIV/AIDS at the World Health Organization (WHO). He has dedicated himself to health and social justice work for more than two decades, helping to provide medical treatment to underserved populations worldwide. Before assuming the Dartmouth presidency, President Kim held professorships at Harvard Medical School and the Harvard School of Public Health. He also served as chair of the Department of Global Health and Social Medicine at Harvard Medical School, chief of the Division of Global Health Equity at Brigham and Women’s Hospital, and director of the François Xavier Bagnoud Center for Health and Human Rights at the Harvard School of Public Health. He continues to serve on the board of PIH. Born in Seoul, Korea, President Kim moved to the United States at the age of five. He graduated with an A.B. magna cum laude from Brown University in 1982. He earned an M.D. from Harvard Medical School in 1991 and a Ph.D. in anthropology from Harvard University in 1993.
Dr. Paul Chew is senior vice president, chief science officer, and chief medical officer at Sanofi, U.S. Between 2007 and 2009 Dr. Chew held the position of president, U.S. research & development, and vice president, therapeutic department head, metabolism, diabetes and thrombosis in which role he was responsible for Lovenox, Lantus, and the therapeutic development portfolio. In addition, he is a member of the PhRMA Science & Regulatory Affairs Executive Committee and the Institute of Medicine Value & Science-Driven Healthcare Roundtable. From 2001-2004, U.S. Dr. Chew was vice president, global head of metabolism and diabetes at Aventis Pharmaceuticals. Prior to joining Aventis, Dr. Chew was at the Bristol-Myers Squibb Company, starting in 1992 as medical director of clinical cardiovascular development. Dr. Chew was vice president, U.S. medical affairs from 1999-2001 where he was responsible for Plavix, Avapro, Glucophage, and Pravachol. Prior to industry, Dr. Chew was assistant professor at The Johns Hopkins Hospital, attending physician in radiology, director of the Pacemaker Clinic and a member of the interventional cardiology staff. Dr. Chew obtained his medical education at The Johns Hopkins School of Medicine.
Dr. Vas Narasimhan recently became global head, vaccines development for Novartis Vaccines and Diagnostics. He is responsible for the clinical development of the vaccine pipeline with over 25 projects and nearly 100 annual global clinical trials. Previously, Vas was head, Novartis Vaccines North America and US country head for Novartis Vaccines and Diagnostics, during which he drove strong growth in the region, built a fully integrated organization that successfully launched Menveo (MenACWY), created new seasonal flu distribution channels, and executed pandemic influenza programs. Vas has served in roles of increasing responsibility at Novartis including as Vice President of US Marketing, Meningitis Franchise Head, Global Marketing, Menveo Brand Director and Head of Portfolio Strategy for the Office of the CEO at Novartis Pharma AG. He worked in the Pharmaceuticals and Medical Products Practice at McKinsey & Co., consulting major pharmaceutical and healthcare companies on a range of initiatives, including large-scale M&A activity and top-level corporate strategy. Vas earned his medical degree from Harvard Medical School and obtained his MPP in International Health Care Policy from Harvard’s John F. Kennedy School of Government. He received his bachelor’s degree in Biological Sciences from University of Chicago.
Derek Yach has played a leading global role in many aspects of NCDs within the private, public and Foundation world for the last 2 decades. He is senior vice president of Global Health and Agricultural Policy at PepsiCo and leads new initiatives related to sustainable agriculture and nutrition in Africa. He has headed global health at the Rockefeller Foundation, been Professor of Global Health at Yale University, and is a former Executive Director of the World Health Organization (WHO). At the WHO he served as cabinet director under Director-General Gro Harlem Brundtland for Non Communicable Diseases and Mental Health where he led development of WHO’s Framework Convention on Tobacco Control, the Global Strategy on Diet and Physical Activity and WHO’s World Health Report on Mental Health. Dr. Yach established the Centre for Epidemiological Research at the South African Medical Research Council. He has authored or co-authored over 200 articles covering the breadth of global health. These include leading thought pieces within NCDs over the last 20 years. He serves on advisory boards of the Clinton Global Initiative, the Chicago Council on International Affairs’ Agricultural Development Initiative, the World Economic Forum’s New Vision for Agriculture, the NIH’s Fogarty International Centre and the World Food Program USA. He is regular plenary speaker and moderator of global and national meetings related to health and development. Dr. Yach has degrees in medicine (Cape Town), public health (Johns Hopkins) and an honorary DSc from Georgetown University.
President Jim Yong Kim (Moderator) took office as the 17th president of Dartmouth College in July 2009. He is a co-founder of Partners in Health (PIH) and a former director of the Department of HIV/AIDS at the World Health Organization (WHO). He has dedicated himself to health and social justice work for more than two decades, helping to provide medical treatment to underserved populations worldwide. Before assuming the Dartmouth presidency, President Kim held professorships at Harvard Medical School and the Harvard School of Public Health. He also served as chair of the Department of Global Health and Social Medicine at Harvard Medical School, chief of the Division of Global Health Equity at Brigham and Women’s Hospital, and director of the François Xavier Bagnoud Center for Health and Human Rights at the Harvard School of Public Health. He continues to serve on the board of PIH. Born in Seoul, Korea, President Kim moved to the United States at the age of five. He graduated with an A.B. magna cum laude from Brown University in 1982. He earned an M.D. from Harvard Medical School in 1991 and a Ph.D. in anthropology from Harvard University in 1993.
Healthcare Breakout Session
Dr. Srishti Gupta is a senior practice expert in McKinsey & Company’s Boston Office, where she focuses her work on non-profit clients in the Global Public Health Sector. Before locating in the US, she worked out of our Swiss office, developing our Global Health practice work in Europe and Africa. Prior to becoming a Practice Expert, Srishti was an Engagement Manager in the Pharmaceutical and Medical Products Practice where she worked on market assessments, clinical operations, and strategy for products. Prior to joining McKinsey, she worked as a consultant for the Taskforce for Global Health. Additionally, she has worked with the Ministry of Health in Peru and in a hospital in Tanzania as a clinical physician in the department of tropical dermatology. She has also worked in India with rural adolescents and street children and has published several papers on the health of these special populations. Srishti has a B.A. and M.A. in Molecular/Cellular Biology from Harvard University, an M.Phil. in Natural Science/Pathology from the University of Cambridge, an M.D. from Harvard Medical School and an M.P.P. in health policy and international development from the John F. Kennedy School of Government.